You are here: Industry Insights > COVID-19

News List

Leinco, Vanderbilt University Medical Center to Deliver Rapid COVID-19 Test americanpharmaceuticalreview
April 30, 2020
Leinco Technologies announced an agreement with Vanderbilt University Medical Center (VUMC) to scale up production of its most promising antibodies for development of a rapid, point of care COVID-19 diagnostic test.
Santhera, Cold Spring Harbor Lab to Investigate Lonodelestat in COVID-19-related ARDS americanpharmaceuticalreview
April 30, 2020
Santhera Pharmaceuticals has entered into a collaboration agreement with Cold Spring Harbor Laboratory (CSHL) to investigate the potential of lonodelestat (POL6014), a potent inhibitor of human neutrophil elastase (hNE).
Romark Initiates Phase 3 Clinical Trials Of NT-300 for COVID-19 americanpharmaceuticalreview
April 30, 2020
Romark will initiate two clinical trials of its investigational new drug candidate NT-300 (nitazoxanide extended-release tablets) for prevention of COVID-19 and other viral respiratory illnesses in high-risk populations.
Spanish Medicines Agency Authorizes Aplidin, APLICOV-PC Trial for COVID-19 americanpharmaceuticalreview
April 30, 2020
PharmaMar has announced the start of the APLICOV-PC clinical trial with Aplidin® (plitidepsin), for the treatment of patients with COVID-19, which has been authorized by the Spanish Medicines and Healthcare Products Agency (AEMPS).
Gilead announces primary endpoints met in Phase III remdesivir trial europeanpharmaceuticalreview
April 30, 2020
Gilead has said that topline results for clinical recovery have been demonstrated in a Phase III trial of remdesivir, tested in COVID-19 patients.
WHO calls for pharma to rapidly distribute malaria prevention and treatment tools europeanpharmaceuticalreview
April 30, 2020
In light of the COVID-19 pandemic, WHO has asked the pharmaceutical supply chain to swiftly distribute nets and antimalarial medicines in sub-Saharan Africa.
Researchers design first new polio vaccine in 50 years europeanpharmaceuticalreview
April 30, 2020
A polio vaccine designed to be incapable of evolving the ability to cause disease in humans has shown promise in a Phase I clinical trial.
Merck signs Covid-19 research alliance with ISB pharmaceutical-technology
April 30, 2020
Merck (MSD) has entered a research collaboration with the Institute for Systems Biology (ISB) to study molecular mechanisms of SARS-CoV-2 and Covid-19 infection.
Santhera explores lonodelestat to treat ARDS in Covid-19 patients pharmaceutical-technology
April 30, 2020
Swiss-based Santhera Pharmaceuticals has partnered with Cold Spring Harbor Laboratory (CSHL) to explore the use of lonodelestat (POL6014) as a potential treatment for acute respiratory distress syndrome (ARDS) caused by Covid-19.
Scancell to develop DNA vaccine candidate against Covid-19 pharmaceutical-technology
April 30, 2020
Immunotherapies developer Scancell has launched a research programme focused on the development of a DNA vaccine candidate to protect from Covid-19.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page